CoChat

Increased Insulin-Like Growth Factor II Production and Consequent Suppression of Growth Hormone Secretion: A Dual Mechanism for Tumor-Induced Hypoglycemia

RON, DAVID, POWERS, ALVIN C., PANDIAN, MURUGAN R., GODINE, JOHN E., AXELROD, LLOYD · 1989 · The Journal of Clinical Endocrinology & Metabolism
Cited by 77

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

We investigated the pathophysiology of fasting hypoglycemia associated with large tumors of mesenchymal origin. We studied two patients with symptomatic fasting hypoglycemia (plasma glucose, 1.92 and 2.03 mmol/L) and a large mesenchymal neoplasm. Before therapy, the plasma insulin-like growth factor II (IGF-II) level measured by RIA was elevated (1879 and 1084 micrograms/L; normal range, 358-854 micrograms/L), the serum GH response to hypoglycemia was impaired, and the plasma IGF-I level was low in both patients. After treatment of the tumor, all of these abnormalities resolved in both patients. Northern blot analysis of tumor RNA revealed extremely high levels of IGF-II mRNA (greater than 100-fold higher than those in normal adult liver). Tumor fragments released IGF-II into tissue culture medium (2.1 and 7.2 micrograms IGF-II/g tissue.24 h). These findings indicate that secretion of IGF-II into the circulation by the tumor was the likely source of the elevated plasma IGF-II levels. We suggest that the primary event in tumor-induced hypoglycemia is overproduction of IGF-II by the tumor, which gives rise to hypoglycemia by a dual mechanism: increased glucose utilization mediated by the insulin-like actions of IGF-II and inhibition of GH secretion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-68-4-701

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 77

Metadata

Authors
RON, D., POWERS, A. C., PANDIAN, M. R., GODINE, J. E., & AXELROD, L.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1989-04
Volume
68
Issue
4
Pages
701-706
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2058860650
Cited by
77
References
1
FWCI
7.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Insulin-Like Growth Factor II Production and Consequent Suppression of Growth Hormone Secretion: A Dual Mechanism for Tumor-Induced Hypoglycemia. https://app.cochat.ai/papers/10.1210/jcem-68-4-701
The paper
RON, D., POWERS, A. C., PANDIAN, M. R., GODINE, J. E., & AXELROD, L. (1989). Increased Insulin-Like Growth Factor II Production and Consequent Suppression of Growth Hormone Secretion: A Dual Mechanism for Tumor-Induced Hypoglycemia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-68-4-701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.